Method for characterizing activity of clostridial neurotoxin or identifying clostridial neurotoxin for therapeutic and / or cosmetic use, genetically engineered cell and method of producing the same, and assay for determining activity of modified or recombinant clostridial neurotoxin

TW202639844APending Publication Date: 2026-10-01IPSEN BIOPHARM LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115115514
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-06-07
Filing Date
2020-06-05
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001079689_001
    Figure TWG2TA001079689_001
  • Figure TWG2TA001079689_002
    Figure TWG2TA001079689_002
  • Figure TWG2TA001079689_003
    Figure TWG2TA001079689_003
Patent Text Reader

Abstract

A cell that has been genetically engineered to be highly sensitive to clostridial neurotoxin, for example, botulinum neurotoxin and tetanus neurotoxin, or modified or recombinant versions thereof. A method for making such a genetically-engineered cell and a method for using such a cell in assaying the activity of modified or recombinant clostridial neurotoxins.
Need to check novelty before this filing date? Find Prior Art